Search Results 381-390 of 16283 for GLP-1 agonist
If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Succinylcholine. Other ...
... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.
... 1 trial. Phase 4 ... weeks prior to entering the run-in period. 11. Patients who have been treated with GLP-1 antagonists in the past must have a wash-out
Do not take any medicines by mouth within 1 hour before taking this medicine. Oral medicines may not be absorbed properly while you are cleaning out your colon.
When it comes to medications, one size does not fit all. One of the areas where precision medicine has made the biggest impact is in developing tests to ...
The purpose of this study is to determine the maximum tolerated dose, and evaluate its safety, tolerability, preliminary clinical effects, and drug/body ...
The objective of this study is to determine the safety, pharmacokinetics, maximum tolerated dose/recommended Phase 2 dose, and efficacy of PLX7486.
The purpose of this study is designed to evaluate the effectiveness and safety of intravenous Lucassin® (terlipressin) versus a placebo for the treatment of ...
If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Alacepril; Amiloride; Amygdalin ...
During the early phases (phases 1 and 2) ... 1 trial. Phase 4 trials look at long-term safety ... agonist pioglitazone, with or without weight loss ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!